Perspective Therapeutics (CATX) Retained Earnings (2011 - 2026)

Perspective Therapeutics recorded quarterly Retained Earnings of -$361.0 million in Q1 2026, down 7.82% quarter-over-quarter from -$334.8 million in Q4 2025, and down 44.47% year-over-year from -$650.2 million in Q1 2025.

Perspective Therapeutics' Retained Earnings history runs 16 years deep, the most recent figure standing at -$361.0 million for Q1 2026.

  • In Q1 2026, Retained Earnings fell 44.47% year-over-year to -$361.0 million; the TTM figure through Mar 2026 stood at -$361.0 million (down 44.47% YoY), while the FY2025 annual figure was -$334.8 million, down 656449.02% from the prior year.
  • Retained Earnings came in at -$361.0 million for Q1 2026 at Perspective Therapeutics, down from -$334.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$51000.0 in Q4 2024 to a low of -$361.0 million in Q1 2026.
  • A 5-year average of -$173.8 million and a median of -$152.4 million in 2023 frame the typical range for Retained Earnings.
  • Across the five-year window, Retained Earnings jumped 99.97% in 2024 and sank 656449.02% in 2025, its largest moves.
  • Perspective Therapeutics' Retained Earnings stood at -$105.9 million in 2022, then sank by 43.9% to -$152.4 million in 2023, then surged by 99.97% to -$51000.0 in 2024, then tumbled by 656449.02% to -$334.8 million in 2025, then decreased by 7.82% to -$361.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$361.0 million, -$334.8 million, and -$297.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 49.96 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -583.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 32.30 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -398.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -221.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 106.20 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.65 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -113.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -361.03 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -361.03 Mn
Dec 31, 2025 -334.84 Mn
Sep 30, 2025 -297.35 Mn
Jun 30, 2025 -271.38 Mn
Mar 31, 2025 -249.90 Mn
Dec 31, 2024 -51,000.00
Sep 30, 2024 -191.55 Mn
Jun 30, 2024 -176.40 Mn
Mar 31, 2024 -164.70 Mn
Dec 31, 2023 -152.44 Mn
Sep 30, 2023 -127.77 Mn
Jun 30, 2023 -117.41 Mn
Mar 31, 2023 -106.30 Mn
Dec 31, 2022 -105.93 Mn
Sep 30, 2022 -102.67 Mn
Jun 30, 2022 -98.60 Mn
Mar 31, 2022 -96.52 Mn
Dec 31, 2021 -95.17 Mn
Sep 30, 2021 -93.57 Mn
Jun 30, 2021 -91.33 Mn
Mar 31, 2021 -90.26 Mn
Dec 31, 2020 -89.52 Mn
Sep 30, 2020 -88.65 Mn
Jun 30, 2020 -87.94 Mn
Mar 31, 2020 -86.75 Mn
Dec 31, 2019 -86.21 Mn
Sep 30, 2019 -85.31 Mn
Jun 30, 2019 -84.49 Mn
Mar 31, 2019 -83.40 Mn
Dec 31, 2018 -82.27 Mn
Sep 30, 2018 -80.86 Mn
Jun 30, 2018 -79.35 Mn
Mar 31, 2018 -76.95 Mn
Dec 31, 2017 -75.61 Mn
Sep 30, 2017 -74.15 Mn
Jun 30, 2017 -72.60 Mn
Mar 31, 2017 -70.75 Mn
Dec 31, 2016 -69.39 Mn
Sep 30, 2016 -67.94 Mn
Jun 30, 2016 -66.44 Mn
Mar 31, 2016 -65.26 Mn
Dec 31, 2015 -64.06 Mn
Jun 30, 2015 -61.73 Mn
Jun 30, 2014 -58.05 Mn
Mar 31, 2014 -56.37 Mn
Dec 31, 2013 -54.29 Mn
Sep 30, 2013 -53.36 Mn
Jun 30, 2013 -52.09 Mn
Mar 31, 2013 -51.10 Mn
Dec 31, 2012 -50.38 Mn
Sep 30, 2012 -49.23 Mn
Jun 30, 2012 -48.23 Mn
Mar 31, 2012 -47.03 Mn
Dec 31, 2011 -46.48 Mn
Sep 30, 2011 -45.85 Mn
Jun 30, 2011 -44.75 Mn